SG & A expenses of Japanese pharmaceutical companies in Korea were higher than those of domestic pharmaceutical companies

According to the SG & A expenses of 7 Japanese pharmaceutical companies which entered into domestic market in last year, SG & A expenses were higher than those of domestic pharmaceutical companies.

The average SG & A expenses ratio of 7 Japanese pharmaceutical companies which are composed of 5 companies including Astellas Pharmaceutical Korea which settle accounts in the end of May, and 2 comp...